Avita Medical
RCEL
Avita Medical (RCEL) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $64.81 M
According to Avita Medical 's latest financial reports the company's total liabilities are $64.81 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Avita Medical - Total liabilities on balance sheet (from 2020 to 2019)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $62.58 M | 362.76% |
| 2022-12-31 | $13.52 M | |
| 2021-06-30 | $9.84 M | -2.14% |
| 2020-06-30 | $10.06 M | 189.28% |
| 2019-06-30 | $3.47 M | 59.28% |
| 2018-06-30 | $2.18 M | 45.21% |
| 2017-06-30 | $1.5 M | 53.99% |
| 2016-06-30 | $0.97 M | 35.3% |
| 2015-06-30 | $0.72 M | -54.43% |
| 2014-06-30 | $1.58 M | -22.52% |
| 2013-06-30 | $2.04 M | -9.37% |
| 2012-06-30 | $2.25 M | 37.39% |
| 2011-06-30 | $1.64 M | -49.72% |
| 2010-06-30 | $3.26 M | 304.74% |
| 2009-06-30 | $0.8 M | -66.95% |
| 2008-06-30 | $2.44 M | 166.04% |
| 2007-06-30 | $0.91 M | -36% |
| 2006-06-30 | $1.43 M | |
| 2004-06-30 | $0.33 M | |
| 2002-12-31 | $0.2 M | -40.19% |
| 2001-12-31 | $0.34 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $2.74 M | -95.76% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | 88.25% | 🇬🇧 UK |
 Novavax NVAX | $2.22 B | 3,326.25% | 🇺🇸 USA |
 Novocure
NVCR | $0.76 B | 1,075.82% | Jersey |